CLINICAL_TRIALS
research
· 2025-12-24
Clinical Trial Update: THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation [NA]
Summary
A clinical trial is recruiting to assess THRIVE Well Cancer FDTN/Exercise with creatine supplementation in breast cancer patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Breast Cancer, Breast Cancer Female | NA | Status: RECRUITING